Alzheimer's & Dementia

Angiotensin receptor blockers and dementia risk in older adults: A target trial emulation

By Hisashi Noma, Hiroshi Sunada, Taiki Sugimoto, Haruhisa Fukuda

Cohort study of 52,019 peopleInterventions

Declared ties to: GSK, Kowa and Sony

The paper

Hisashi Noma, Hiroshi Sunada, Taiki Sugimoto, Haruhisa Fukuda

The Graduate University for Advanced Studies, SOKENDAI; Kyushu University

Alzheimer's & Dementia, 1 Aug 2026

doi.org/10.1002/alz.71692 PubMed 42621843

Drugs & Aging4 Oct 2026
RAS inhibitors linked to lower dementia risk than CCBs
Drug Design, Development and Therapy5 Oct 2026
GLP-1 agonists linked to lower dementia risk after COVID-19
Diabetes & Vascular Disease Research4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Journal of Alzheimer's Disease9 Oct 2026
Benzodiazepine use shows only a modest link to dementia